Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Garneau

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Metabolism: Clinical and Experimental|August 5, 2003
Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetesPaul Poirier, Peter Bogaty, François Philippon, et al.
Medicine and Science in Sports and Exercise|November 8, 2007
Normalization of diastolic dysfunction in type 2 diabetics after exercise trainingPatrice Brassard, Sylvie Legault, Caroline Garneau, et al.
Vaccines|January 13, 2021
Modulation of Antigen Display on PapMV Nanoparticles Influences Its ImmunogenicityMarie-Eve Laliberté-Gagné, Marilène Bolduc, Caroline Garneau, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|November 29, 2007
Safety and magnitude of changes in blood glucose levels following exercise performed in the fasted and the postprandial state in men with type 2 diabetesThierry Gaudet-Savard, Annie Ferland, Tom L Broderick, et al.
Vaccines|June 20, 2019
Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine PlatformMarie-Ève Laliberté-Gagné, Marilène Bolduc, Ariane Thérien, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 9, 2018
The quest for a nanoparticle-based vaccine inducing broad protection to influenza virusesMarilène Bolduc, Mariana Baz, Marie-Ève Laliberté-Gagné, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 7, 2025
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from ImidazoquinolinesMarilène Bolduc, Philippe Saint-Louis, Damien Carignan, et al.
Vaccines|April 27, 2026
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 VariantsLéa-J Blanchette, Marilène Bolduc, Tekeleselassie Woldemariam, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 19, 2022
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infectionSanta-Mariela Olivera-Ugarte, Marilène Bolduc, Marie-Ève Laliberté-Gagné, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Metabolism: Clinical and Experimental|August 5, 2003
Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetesPaul Poirier, Peter Bogaty, François Philippon, et al.
Medicine and Science in Sports and Exercise|November 8, 2007
Normalization of diastolic dysfunction in type 2 diabetics after exercise trainingPatrice Brassard, Sylvie Legault, Caroline Garneau, et al.
Vaccines|January 13, 2021
Modulation of Antigen Display on PapMV Nanoparticles Influences Its ImmunogenicityMarie-Eve Laliberté-Gagné, Marilène Bolduc, Caroline Garneau, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|November 29, 2007
Safety and magnitude of changes in blood glucose levels following exercise performed in the fasted and the postprandial state in men with type 2 diabetesThierry Gaudet-Savard, Annie Ferland, Tom L Broderick, et al.
Vaccines|June 20, 2019
Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine PlatformMarie-Ève Laliberté-Gagné, Marilène Bolduc, Ariane Thérien, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 9, 2018
The quest for a nanoparticle-based vaccine inducing broad protection to influenza virusesMarilène Bolduc, Mariana Baz, Marie-Ève Laliberté-Gagné, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 7, 2025
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from ImidazoquinolinesMarilène Bolduc, Philippe Saint-Louis, Damien Carignan, et al.
Vaccines|April 27, 2026
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 VariantsLéa-J Blanchette, Marilène Bolduc, Tekeleselassie Woldemariam, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 19, 2022
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infectionSanta-Mariela Olivera-Ugarte, Marilène Bolduc, Marie-Ève Laliberté-Gagné, et al.
Pageof 1